Contract Awarded For Saizen a Drug Containing The Growth Hormone Somatropin Produced By Recombinant Dna Technology. The Main Effect Is To Increase The Growth Of Children And Adolescents And To Treat Adults With Growth Hormone Deficiency. The Drug Is Indic
TK ID 521369258
Document Type
Contract Awards
Tender Summary
Contract Awarded For Saizen a Drug Containing The Growth Hormone Somatropin Produced By Recombinant Dna Technology. The Main Effect Is To Increase The Growth Of Children And Adolescents And To Treat Adults With Growth Hormone Deficiency. The Drug Is Indic
Action Deadline
17 Jan 2026
Don't have an account yet?Sign up here.